BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...

Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71 st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi ...

PARIS, February 14 Sanofi-aventis announcedtoday that the Chicago Athenaeum Museum of Architecture and Design hasawarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposableinsulin ...

Sanofi-aventis has won FDA approval for Apidra SoloSTAR, a prefilled disposable pen, for children with type 1 diabetes and adults with type 1 or 2 diabetes. Apidra, which has been on the market in the ...

Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes - Findings Presented at European Association for the Study of Diabetes ...

Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2018-01670 (PTAB) Sept. 10, 2018 N/A Lantus® SoloStar® (insulin glargine recombinant for injection), Apidra® SoloStar® (insulin glulisine ...

The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...

treatment satisfaction, better quality of life and lower fear of hypoglycemia vs those using a premixed insulin product. - DQoL improved significantly for all groups at all wks; average improvement ...

Sanofi announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus(R) and/or Apidra ...

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with ...